Clinical Trials List
2023-06-01 - 2027-12-31
Phase I/II
Recruiting5
ICD-10C69.40
Malignant neoplasm of unspecified ciliary body
ICD-10C69.41
Malignant neoplasm of right ciliary body
ICD-10C69.42
Malignant neoplasm of left ciliary body
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9190.0
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳威君 無
- Chyong-Huey Lai 無
- 張宸斌 無
- Yun-Hsin Tang 無
- Cheng-Tao Lin 無
- 董秀蓉 無
- 張宸斌 無
- 周宏學 無
- 董秀蓉 無
- 張淑涵 無
- Gigin Lin 無
- Angel Chao 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-YUN SHAO 無
- Wei-Wu Chen 無
- Chih-Hung Hsu 無
- 張端瑩 無
- Wen-Fang Cheng 無
- 徐偉勛 無
- TSUNG-HAO LIU 無
- WEI-LI MA 無
- Jih-Hsiang Lee 無
- YEN-SHEN LU 無
- 黃柏翔 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen 無
- Jui-Hung Tsai 無
- Chun-Hui Lee 無
- 楊舜如 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
445 participants
